Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-09
1995-11-07
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 546114, 548252, C07D40312, C07D49504, A61K 3144, A61K 3141
Patent
active
054648556
ABSTRACT:
Thiophene-2-carboxamidotetrazoles inhibit the Mac-1 integrin and are thus useful for treating diseases mediated by Mac-1 adhesion, including inflammatory disorders.
REFERENCES:
The Journal of Immunology, vol. 144, No. 7, Apr. 1990; Shappell et al., pp. 2702-2711.
Journal of Leukocyte Biology, vol. 48, 1990, Rosen, pp. 465-469.
The Journal of Immunology, vol. 150, No. 6, Mar. 1993, Mulligan et al., pp. 2401-2406.
Circulation, vol. 81, No. 1, Jan. 1990, Simpson et al., pp. 226-237.
Gastroenterology, vol. 100, No. 4, 1991, Wallace et al., pp. 878-883.
American Journal of Physiology, vol. 259, 1990, Wallace et al., pp. G462-G467.
Capiris Thomas
Connor David T.
Ashbrook Charles W.
Springer David B.
Warner-Lambert & Company
LandOfFree
Thiophene-2-carboxamidotetrazoles and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophene-2-carboxamidotetrazoles and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophene-2-carboxamidotetrazoles and pharmaceutical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-197557